Answers are grounded in this paper and cite their sources.
Case report highlights severe methemoglobinemia following prilocaine infiltration in an anemic patient, suggesting vigilance in dosing and early intervention.
Methemoglobinemia is an uncommon but potentially life-threatening cause of tissue hypoxia in the emergency Department (ED), often presenting with a characteristic mismatch between low pulse oximetry readings and normal arterial oxygen tension. Prilocaine is a well-recognized trigger due to its oxidizing metabolite o-toluidine, and risk is further amplified when high volumes are infiltrated into highly vascular mucosal sites.We describe a 30-year-old woman who presented to the ED one hour after external hemorrhoidectomy under local anesthesia with sudden-onset weakness, dizziness, and marked central and peripheral cyanosis. She had received 800 mg of prilocaine (≈11.4 mg/kg) and 15 mg of bupivacaine via perianal infiltration. On arrival, she was hemodynamically stable but had SpO₂ 75% on room air, unresponsive to oxygen. Arterial blood gas revealed pH 7.41, PaO₂ 110 mmHg, and lactate 3.8 mmol/L; co-oximetry showed MetHb 38%. Laboratory tests demonstrated microcytic iron-deficiency anemia (Hb 7.3 g/dL). Intravenous methylene blue 100 mg (≈1.4 mg/kg) was administered over 5 minutes with rapid clinical improvement; MetHb fell to 15% at 6 hours and 6.5% at 24 hours without evidence of hemolysis.This case highlights a high-risk triad of mucosal prilocaine use, weight-based overdose, and unrecognized anemia, underscoring the need for strict dosing vigilance, early consideration of dyshemoglobinemia, and timely antidotal therapy in the ED.
No takes yet. Share an insight, caveat, or question.
Aksakal et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: